Search

everythinglearnresearchcommunity

for

Search:↓

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Certain medications can help treat PCOS symptoms, but they aren't FDA-approved for this use.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Portable point-of-care testing can improve quick and accurate genetic disorder detection.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Cationic polymers improved liposome stability and increased skin absorption of aciclovir and minoxidil.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

Efficient delivery systems are needed for the clinical use of CRISPR-Cas9 gene editing.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Intralesional cidofovir may be a viable alternative treatment for SCC.

Biosimilars lower costs but don't significantly improve access.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

ELIP-based CRISPR delivery improves heart disease gene editing but needs more testing.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Finasteride complexes with HPβCD and polymers improve solubility, potentially enhancing hair loss treatment.